Suppr超能文献

编码可溶性肿瘤坏死因子α受体免疫球蛋白的腺病毒可延长共转染的报告基因在大鼠肺中的基因表达。

Adenovirus encoding soluble tumor necrosis factor alpha receptor immunoglobulin prolongs gene expression of a cotransfected reporter gene in rat lung.

作者信息

Suda Takashi, Tagawa Tsutomu, Kanaan Samer A, Kozower Benjamin D, Daddi Niccolò, Mohanakumar T, Patterson G Alexander

机构信息

Division of Cardiothoracic Surgery, Washington University School of Medicine, One Barnes-Jewish Hospital Plaza, 3108 Queeny Tower, St Louis, MO 63110-1013, USA.

出版信息

J Thorac Cardiovasc Surg. 2003 Oct;126(4):1155-61. doi: 10.1016/s0022-5223(03)00939-5.

Abstract

OBJECTIVE

Because almost all pulmonary diseases are not caused by one gene, multiple gene transfection is required for current gene therapy. Adenovirus is an important gene therapy vector, but a short duration and the inability of repeated administration remain limitations. The aims of this study were to evaluate whether adenoviral vector encoding soluble tumor necrosis factor alpha receptor immunoglobulin and beta-galactosidase cotransfection prolongs gene expression and facilitates repeated vector administration to investigate the feasibility of a cotransfection strategy.

METHODS

F344 rats received intratracheal administration of 1 x 10(9) plaque-forming units of adenoviral vector encoding beta-galactosidase or both adenoviral vector encoding beta-galactosidase and adenoviral vector encoding soluble tumor necrosis factor alpha receptor immunoglobulin. In the expression study beta-galactosidase gene expression in the lung was examined by means of enzyme-linked immunosorbent assay on days 2, 7, 14, 28, and 56 (n = 4/day). In the repeated transfection study, soluble tumor necrosis factor alpha receptor immunoglobulin and beta-galactosidase were readministered once (7 days after the first adenovirus administration) or twice (on days 7 and 14; n = 4/day). A 2-way factorial analysis of variance was used for statistical analysis.

RESULTS

Soluble tumor necrosis factor alpha receptor immunoglobulin and beta-galactosidase cotransfection prolonged the duration of beta-galactosidase expression. However, antiadenovirus antibody production was significantly increased in the cotransfection group. In addition, there was no increase in beta-galactosidase expression after readministration of soluble tumor necrosis factor alpha receptor immunoglobulin and beta-galactosidase.

CONCLUSION

Adenoviral vector encoding soluble tumor necrosis factor alpha receptor immunoglobulin and beta-galactosidase cotransfection prolongs beta-galactosidase expression but does not increase beta-galactosidase expression after repeated administration. These results suggest that tumor necrosis factor alpha is one of the most important factors in regulating the duration of gene expression. The cotransfection approach is feasible, but the increase of antiadenovirus antibodies might make repeated cotransfection unfeasible.

摘要

目的

由于几乎所有肺部疾病都不是由单个基因引起的,当前的基因治疗需要进行多基因转染。腺病毒是一种重要的基因治疗载体,但作用持续时间短和无法重复给药仍是其局限性。本研究的目的是评估编码可溶性肿瘤坏死因子α受体免疫球蛋白和β-半乳糖苷酶的腺病毒载体共转染是否能延长基因表达并便于重复给予载体,以研究共转染策略的可行性。

方法

F344大鼠经气管内给予1×10⁹ 个空斑形成单位的编码β-半乳糖苷酶的腺病毒载体,或同时给予编码β-半乳糖苷酶的腺病毒载体和编码可溶性肿瘤坏死因子α受体免疫球蛋白的腺病毒载体。在表达研究中,于第2、7、14、28和56天(每天n = 4)通过酶联免疫吸附测定法检测肺组织中β-半乳糖苷酶基因的表达。在重复转染研究中,在首次给予腺病毒7天后再次给予可溶性肿瘤坏死因子α受体免疫球蛋白和β-半乳糖苷酶一次,或在第7天和第14天再次给予两次(每天n = 4)。采用双向析因方差分析进行统计分析。

结果

可溶性肿瘤坏死因子α受体免疫球蛋白和β-半乳糖苷酶共转染延长了β-半乳糖苷酶的表达持续时间。然而,共转染组中抗腺病毒抗体的产生显著增加。此外,再次给予可溶性肿瘤坏死因子α受体免疫球蛋白和β-半乳糖苷酶后,β-半乳糖苷酶的表达并未增加。

结论

编码可溶性肿瘤坏死因子α受体免疫球蛋白和β-半乳糖苷酶的腺病毒载体共转染可延长β-半乳糖苷酶的表达,但重复给药后并不会增加β-半乳糖苷酶的表达。这些结果表明肿瘤坏死因子α是调节基因表达持续时间的最重要因素之一。共转染方法是可行的,但抗腺病毒抗体的增加可能使重复共转染不可行。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验